Effect of Yogurts Supplemented With Mobilee on Joint Function in Healthy Individuals With Joint Discomfort

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-09-30

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether the daily eating of a yogurt supplemented with Mobile is effective in improving joint function and quality of life of individuals with low intensity gonalgia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Consuming a Bioactive Compound (EPP) on Joint Health in Healthy Adults

NCT06650670

Knee Discomfort

TERMINATED NA

LIKEST Study: Lipocet® in Adults With Primary Knee Osteoarthritis Grade 3-4

NCT06134115

Primary Knee Osteoarthritis Grade 3 - 4

COMPLETED NA

Influence of Instaflex Advanced Supplement on Joint Function

NCT03041077

Knee Discomfort

COMPLETED NA

A Placebo-Controlled Study of Collagen Hydrolysate in Subjects With Knee Osteoarthritis (OA)

NCT00536302

Knee Osteoarthritis (OA)

COMPLETED PHASE2/PHASE3

Instaflex and Joint Pain in Community Adults

NCT01956500

Joint Pain, Stiffness, Function

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The prevalence of low intensity gonalgia is relatively high in western population. The purpose of the present intervention study is to determine whether the daily consumption of a yogurt supplemented with Mobile is effective in improving joint function and quality of life of individuals with low intensity gonalgia. Previous research using in vitro and animal models have demonstrated the efficacy of Mobilee in reducing inflammation and promoting anabolic responses in joint tissues. In addition, in two previous human intervention trials, the effects of Mobilee in joint function had been assessed using isokinetic tests. The present trial aims to confirm those previous results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Intensity Knee Gonalgia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mobilee yogurt

Subjects eating daily on yogurt supplemented with Mobilee

Group Type EXPERIMENTAL

Yogurt supplemented with Mobilee

Intervention Type DIETARY_SUPPLEMENT

One yogurt (125mL) per day including 80mg of Mobilee

Placebo yogurt

Subjects receiving daily a standard yogurt

Group Type PLACEBO_COMPARATOR

Yogurt

Intervention Type DIETARY_SUPPLEMENT

One yogurt (125mL) per day

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Yogurt supplemented with Mobilee

One yogurt (125mL) per day including 80mg of Mobilee

Intervention Type DIETARY_SUPPLEMENT

Yogurt

One yogurt (125mL) per day

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (between 20 and 70 years of age)
* Subject with low intensity knee gonalgia (VAS pain intensity between 3 and 5cm during at least the last 6 months)
* Healthy individual according to its medical records, physical and laboratorial parameters
* Positive informed consent

Exclusion Criteria

* Individuals requiring acetaminophen or any other drug to control pain
* Active rheumatoid arthritis or any other inflammatory joint disease
* Oral treatment with corticosteroids 4 weeks before selection
* Intra-articular treatment with corticosteroids 3 months before selection
* Significant injury of the study joint 12 months before selection
* Individuals receiving any drug or supplement for osteoarthritis
* Individuals requiring any type of medical prescription to control pain

Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes